Filings

6 documents · 13 matches

1. ACRV Acrivon Therapeutics, Inc. 10-Q 2026-08-12

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   tariffs. There can be no assurance that the current operating plan will be achieved or that additional funding will be available
   2 matches in this document Show context Copy citation

2. ACRV Acrivon Therapeutics, Inc. 10-Q 2026-05-13

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   tariffs. There can be no assurances that the current operating plan will be achieved or that additional funding will be available
   2 matches in this document Show context Copy citation

3. ACRV Acrivon Therapeutics, Inc. 10-K 2026-03-19

   Item 1A. Risk Factors.

   tariffs and other barriers to trade, and the recent disruptions to and volatility in the credit and financial markets in the United
   3 matches in this document Show context Copy citation

4. ACRV Acrivon Therapeutics, Inc. 10-Q 2025-11-13

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   tariffs. There can be no assurances that the current operating plan will be achieved or that additional funding will be available
   2 matches in this document Show context Copy citation

5. ACRV Acrivon Therapeutics, Inc. 10-Q 2025-08-13

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   tariffs. There can be no assurances that the current operating plan will be achieved or that additional funding will be available
   2 matches in this document Show context Copy citation

6. ACRV Acrivon Therapeutics, Inc. 10-Q 2025-05-14

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   tariffs. There can be no assurances that the current operating plan will be achieved or that additional funding will be available
   2 matches in this document Show context Copy citation